Skip to main content
Top
Published in: International Urology and Nephrology 8/2017

01-08-2017 | Urology - Original Paper

Idiopathic retroperitoneal fibrosis: clinical features and long-term renal function outcome

Authors: Mohamed H. Zahran, Yasser Osman, Mohamed A. Soltan, Ahmed Elhussein Abolazm, Mostafa K. Ghazy, Ahmed M. Harraz, Ahmed A. Shokeir, Hassan Abol-Enein, Bedeir Ali-El-Dein

Published in: International Urology and Nephrology | Issue 8/2017

Login to get access

Abstract

Purpose

To evaluate the long-term renal function outcome of management of retroperitoneal fibrosis (RPF)-induced ureteral obstruction.

Methods

Thirty-six patients with idiopathic RPF-induced ureteral obstruction were classified according to the management type into two groups, group A; managed by indwelling JJ stent and group B managed by ureterolysis and omental wrapping (UOR). The primary outcome was to define the long-term outcome of management on RF. It was evaluated by changes in serum creatinine and estimated GFR (eGFR) using Modification of Diet in Renal Disease equation where 20% changes in eGFR is considered significant. The second outcome is to compare the outcomes between both groups.

Results

After 27.5 (1–124) months, median (range) follow-up, median (range) serum creatinine increased significantly from 1.5 (0.8–8.1) to 1.6 (1–12.1) mg/dl (p value =0.04) and eGFR showed non-statistical significant reduction from 43 (5–110) to 41 (5–88) ml/min/1.73 m2 (p value =0.3). Eight (22.2%), 12 (34.4%) and 16 (44.4%) patients showed stable, increased and decreased eGFR. Group A showed statistically significant increased serum creatinine and insignificant decreased eGFR (p value =0.04 and 0.09), while group B showed statistically insignificant changes in serum creatinine and eGFR (p value =0.5 and 0.9). In group B, nine (21.4%) renal units are still harboring JJ stents.

Conclusion

For idiopathic RPF, UOR avoided indwelling ureteral stents in 78.6% of renal units with apparent better long-term renal function outcome.
Literature
2.
go back to reference Yachoui R, Sehgal R, Carmichael B (2016) Idiopathic retroperitoneal fibrosis: clinicopathologic features and outcome analysis. Clin Rheumatol 35(2):401–407CrossRefPubMed Yachoui R, Sehgal R, Carmichael B (2016) Idiopathic retroperitoneal fibrosis: clinicopathologic features and outcome analysis. Clin Rheumatol 35(2):401–407CrossRefPubMed
3.
go back to reference Fernando A, Pattison J, Horsfield C et al (2016) A lot of questions (and a few answers …) in retroperitoneal fibrosis. BJU Int 117(1):16–19CrossRefPubMed Fernando A, Pattison J, Horsfield C et al (2016) A lot of questions (and a few answers …) in retroperitoneal fibrosis. BJU Int 117(1):16–19CrossRefPubMed
4.
5.
go back to reference Harraz AM, EL-Nahas AR, Zahran MH et al (2014) Would the indwelling internal ureteral stent influence renal function despite relief of benign ureteral obstruction? J Endourol 28(2):243–247CrossRefPubMed Harraz AM, EL-Nahas AR, Zahran MH et al (2014) Would the indwelling internal ureteral stent influence renal function despite relief of benign ureteral obstruction? J Endourol 28(2):243–247CrossRefPubMed
6.
go back to reference Duchene DA, Winfield HN, Cadeddu JA et al (2007) Multi-institutional survey of laparoscopic ureterolysis for retroperitoneal fibrosis. Urology 69(6):1017–1021CrossRefPubMed Duchene DA, Winfield HN, Cadeddu JA et al (2007) Multi-institutional survey of laparoscopic ureterolysis for retroperitoneal fibrosis. Urology 69(6):1017–1021CrossRefPubMed
7.
go back to reference Heidenreich A, Derakhshani P, Neubauer S et al (2000) Treatment outcomes in primary and secondary retroperitoneal fibrosis. Urol A 39:141–148 (abstract) CrossRef Heidenreich A, Derakhshani P, Neubauer S et al (2000) Treatment outcomes in primary and secondary retroperitoneal fibrosis. Urol A 39:141–148 (abstract) CrossRef
8.
go back to reference Kermani TA, Crowson CS, Achenbach SJ et al (2011) Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes. Mayo Clin Proc 86(4):297–303CrossRefPubMedPubMedCentral Kermani TA, Crowson CS, Achenbach SJ et al (2011) Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes. Mayo Clin Proc 86(4):297–303CrossRefPubMedPubMedCentral
9.
go back to reference Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470CrossRefPubMed Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470CrossRefPubMed
10.
go back to reference Cristian S, Cristian M, Cristian P et al (2015) Management of idiopathic retroperitoneal fibrosis from the urologist’ perspective. Ther Adv Urol 7(2):85–99CrossRefPubMed Cristian S, Cristian M, Cristian P et al (2015) Management of idiopathic retroperitoneal fibrosis from the urologist’ perspective. Ther Adv Urol 7(2):85–99CrossRefPubMed
11.
go back to reference Kardar AH, Kattan S, Lindstedt E et al (2002) Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration. J Urol 168(2):550–555CrossRefPubMed Kardar AH, Kattan S, Lindstedt E et al (2002) Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration. J Urol 168(2):550–555CrossRefPubMed
12.
go back to reference Fry AC, Singh S, Gunda SS et al (2008) Successful use of steroids and ureteric stents in 24 patients with idiopathic retroperitoneal fibrosis: a retrospective study. Nephron Clin Pract 108(3):c213–c220CrossRefPubMed Fry AC, Singh S, Gunda SS et al (2008) Successful use of steroids and ureteric stents in 24 patients with idiopathic retroperitoneal fibrosis: a retrospective study. Nephron Clin Pract 108(3):c213–c220CrossRefPubMed
13.
go back to reference Ilie CP, Pemberton RJ, Tolley DA (2006) Idiopathic retroperitoneal fibrosis: the case for nonsurgical treatment. BJU Int 98:137–140CrossRefPubMed Ilie CP, Pemberton RJ, Tolley DA (2006) Idiopathic retroperitoneal fibrosis: the case for nonsurgical treatment. BJU Int 98:137–140CrossRefPubMed
14.
go back to reference Styn NR, Frauman S, Faerber GJ et al (2011) University of Michigan surgical experience with ureterolysis for retroperitoneal fibrosis: a comparison of laparoscopic and open surgical approaches. Urology 77(2):339–343CrossRefPubMed Styn NR, Frauman S, Faerber GJ et al (2011) University of Michigan surgical experience with ureterolysis for retroperitoneal fibrosis: a comparison of laparoscopic and open surgical approaches. Urology 77(2):339–343CrossRefPubMed
15.
go back to reference Brown JA, Garlitz CJ, Hubosky SG et al (2006) Hand-assisted laparoscopic ureterolysis to treat ureteral obstruction secondary to idiopathic retroperitoneal fibrosis: assessment of a novel technique and initial series. Urology 68(1):46–49CrossRefPubMed Brown JA, Garlitz CJ, Hubosky SG et al (2006) Hand-assisted laparoscopic ureterolysis to treat ureteral obstruction secondary to idiopathic retroperitoneal fibrosis: assessment of a novel technique and initial series. Urology 68(1):46–49CrossRefPubMed
16.
go back to reference Li KP, Zhu J, Zhang JL et al (2011) Idiopathic retroperitoneal fibrosis (RPF): clinical features of 61 cases and literature review. Clin Rheumatol 30(5):601–605CrossRefPubMed Li KP, Zhu J, Zhang JL et al (2011) Idiopathic retroperitoneal fibrosis (RPF): clinical features of 61 cases and literature review. Clin Rheumatol 30(5):601–605CrossRefPubMed
17.
go back to reference Stifelman M, Shah O, Mufarrij P et al (2008) Minimally invasive management of retroperitoneal fibrosis. Urology 71:201–204CrossRefPubMed Stifelman M, Shah O, Mufarrij P et al (2008) Minimally invasive management of retroperitoneal fibrosis. Urology 71:201–204CrossRefPubMed
18.
go back to reference Arvind NK, Singh O, Ali Q et al (2014) Laparoscopic ureterolysis and omental wrapping in patients with retroperitoneal fibrosis and obstructive uropathy: a single-center experience. J Laparoendosc Adv Surg Tech A 24(3):159–164CrossRefPubMed Arvind NK, Singh O, Ali Q et al (2014) Laparoscopic ureterolysis and omental wrapping in patients with retroperitoneal fibrosis and obstructive uropathy: a single-center experience. J Laparoendosc Adv Surg Tech A 24(3):159–164CrossRefPubMed
19.
go back to reference Gao L, Wang H, Xu Y et al (2015) Computed tomography parameters can be used as predictive markers for the improvement of renal function in patients with retroperitoneal fibrosis. Clin Exp Rheumatol 33(6):871–876PubMed Gao L, Wang H, Xu Y et al (2015) Computed tomography parameters can be used as predictive markers for the improvement of renal function in patients with retroperitoneal fibrosis. Clin Exp Rheumatol 33(6):871–876PubMed
Metadata
Title
Idiopathic retroperitoneal fibrosis: clinical features and long-term renal function outcome
Authors
Mohamed H. Zahran
Yasser Osman
Mohamed A. Soltan
Ahmed Elhussein Abolazm
Mostafa K. Ghazy
Ahmed M. Harraz
Ahmed A. Shokeir
Hassan Abol-Enein
Bedeir Ali-El-Dein
Publication date
01-08-2017
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 8/2017
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-017-1608-9

Other articles of this Issue 8/2017

International Urology and Nephrology 8/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.